Morning top 5: AGSI work-to-rule; Olympic Council of Ireland report; and Antarctica reserve

The top stories this Friday morning

Gardaí are stepping up their pay row with another day of industrial action later.

For only the second time ever, AGSI middle-ranking officers will be on a work-to-rule.

From 7.00am they will refuse to use their IT system, process prisoners or do admin work.

Talks between sergeants and inspectors and the Department of Justice stalled earlier this week - but will resume this afternoon.

****

The Olympic Council of Ireland is back in the spotlight as two new reports emerge after the summer games scandal.

One report by Deloitte covers the council's governance while the other by Grant Thornton will focus on the sale of Rio tickets.

The ticketing report will then be sealed and sent to Judge Carroll Moran to form part of his non-statutory inquiry.

****

Hillary Clinton has shared a stage with Michelle Obama for the first time in the US presidential election.

America's First Lady condemned Donald Trump, saying that he "calls on Americans to turn against each other."

Speaking at a rally in North Carolina last night, Mrs Obama said people need to get on the Democratic candidate's side.

She said Mr Trump's vision was based on "hopelessness and despair".

Mrs Clinton, on the other hand, was the most "qualified and prepared candidate for president...in our lifetime".

****

After years of talks, the countries which decide the fate of Antarctica have agreed to create a huge marine reserve.

It will cover around 1.55 million square kilometres, of which three-quarters will be a no-fishing zone.

The 24 countries and the European Union have been meeting in Australia this week and have finally come to an agreement.

****

A male contraceptive injection has been shown to be almost 100% effective.

Some 350 men in the UK took part in a trial over a year - and only four of their partners became pregnant.

The hormone-based jab is designed to lower sperm counts by acting on the brain's pituitary gland.

But a number of reported side effects - including depression and muscle pain - caused 20 men to drop out of the trial.